Canada markets open in 8 hours 56 minutes

Graybug Vision, Inc. (GRAY)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
0.9310-0.0290 (-3.02%)
At close: 04:00PM EDT
0.9700 +0.04 (+4.19%)
After hours: 07:01PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close0.9600
Open0.9600
Bid0.0000 x 2900
Ask0.0000 x 800
Day's Range0.9212 - 0.9900
52 Week Range0.7200 - 3.7700
Volume48,677
Avg. Volume393,574
Market Cap20.033M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-1.6220
Earnings DateNov 09, 2022 - Nov 14, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.17
  • GlobeNewswire

    Graybug Vision Reports Financial Results for the Three and Six Months Ended June 30, 2022, and Recent Corporate Developments

    BALTIMORE, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for ocular diseases, today provided an update on recent corporate developments and anticipated milestones, and reported financial results for the three and six months ended June 30, 2022. Recent Corporate Developments Announced review of strategic alternatives — On June 28, 2022, Graybug announced that its Board of Directors w

  • GlobeNewswire

    Graybug to Present at the 2022 OIS Retina Innovation Summit

    BALTIMORE, July 06, 2022 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of ocular diseases, today announced a platform presentation at the upcoming Ophthalmology Innovation Source (OIS) Retina Innovation Summit, to be held in New York City on July 13, 2022. Information about the event is listed below and available on the OIS Retina website. Graybug Pipeline Opportunities in Retin

  • Zacks

    Graybug (GRAY) to Review Strategic Alternatives, Stock Up

    Graybug's (GRAY) board of directors is set to review strategic options focused on maximizing shareholder value, including a potential sale of the company. Shares rise.